BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piga M, Arnaud L. The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand? J Clin Med 2021;10:E243. [PMID: 33440874 DOI: 10.3390/jcm10020243] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Zhang S, Zhang J, Cheng T, Liu Y, Liu H, Hao M, Chen J. A decreased number of circulating regulatory T cells is associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus. Immunity Inflam & Disease 2022;10. [DOI: 10.1002/iid3.731] [Reference Citation Analysis]
2 Chen H, Shi S, Cui H, Li Y, Liu Z, Yao L, Shen B. What are the predictive factors of body image disturbance in patients with systemic lupus erythematosus? A cross-sectional study in China. BMJ Open 2022;12:e060049. [DOI: 10.1136/bmjopen-2021-060049] [Reference Citation Analysis]
3 Mertz P, Piga M, Chessa E, Amoura Z, Voll RE, Schwarting A, Maurier F, Blaison G, Bonnotte B, Poindron V, Fiehn C, Lorenz HM, Korganow AS, Sibilia J, Martin T, Arnaud L. Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus. RMD Open 2022;8:e002395. [PMID: 36123013 DOI: 10.1136/rmdopen-2022-002395] [Reference Citation Analysis]
4 Piga M, Chessa E, Morand EF, Ugarte-gil MF, Tektonidou M, van Vollenhoven R, Petri M, Arnaud L, Appenzeller S, Aranow C, Askanase A, Avcin T, Bae S, Bertsias G, Bonfa E, Cairoli E, Cardiel MH, Cervera R, Chasset F, Chizzolini C, Clarke AE, Conti F, Costedoat-chalumeau N, Czirják L, Doria A, Dörner T, Espinosa G, Fischer-betz R, Garcìa M, Gladman DD, González LA, Gunnarsson I, Hamijoyo L, Hanly JG, Hasni SA, Houssiau FA, Inanç M, Inês LS, Isenberg D, Jacobsen S, Jan Wu Y, Kaneko Y, Katsumata Y, Lau CS, Legge AC, Lerang K, Limper M, Louthrenoo W, Luo S, Marinho A, Massardo L, Mathian A, Mosca M, Nikpour M, Pego-reigosa JM, Peschken CA, Pons-estel BA, Pons-estel GJ, Rahman A, Rednic S, Ribi C, Ruiz-irastorza G, Sato EI, Saxena A, Schneider M, Sebastiani GD, Strand V, Svenungsson E, Tanaka Y, Tazi Mezalek Z, Tee ML, Tincani A, Touma Z, Troldborg A, Vasconcelos C, Vinet É, Vital EM, Voskuyl AE, Voss A, Wallace D, Ward M, Zamora LD. Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study. The Lancet Rheumatology 2022;4:e441-9. [DOI: 10.1016/s2665-9913(22)00107-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Schlencker A, Messer L, Ardizzone M, Blaison G, Hinschberger O, Dahan E, Sordet C, Walther J, Dory A, Gonzalez M, Kleinlogel S, Bramont-Nachman A, Barrand L, Payen-Revol I, Sibilia J, Martin T, Arnaud L. Improving patient pathways for systemic lupus erythematosus: a multistakeholder pathway optimisation study. Lupus Sci Med 2022;9:e000700. [PMID: 35568439 DOI: 10.1136/lupus-2022-000700] [Reference Citation Analysis]
6 Ma Y, Chen J, Wang T, Zhang L, Xu X, Qiu Y, Xiang AP, Huang W. Accurate Machine Learning Model to Diagnose Chronic Autoimmune Diseases Utilizing Information From B Cells and Monocytes. Front Immunol 2022;13:870531. [DOI: 10.3389/fimmu.2022.870531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Jiang Z, Shao M, Dai X, Pan Z, Liu D. Identification of Diagnostic Biomarkers in Systemic Lupus Erythematosus Based on Bioinformatics Analysis and Machine Learning. Front Genet 2022;13:865559. [DOI: 10.3389/fgene.2022.865559] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Chen Y, Wang L, Cao Y, Li N. Total Glucosides of Paeonia lactiflora for Safely Reducing Disease Activity in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Front Pharmacol 2022;13:834947. [PMID: 35173622 DOI: 10.3389/fphar.2022.834947] [Reference Citation Analysis]
9 Kawato Y, Fukahori H, Nakamura K, Kanno A, Kubo K, Hiramitsu M, Matsuda T, Hanada Y, Furukawa T, Nakajima Y, Kinugasa F, Morokata T. Potential benefit of the cathepsin S inhibitor, ASP1617, as a treatment for systemic lupus erythematosus. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174826] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Parodis I, Studenic P. Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver's Seat in Their Disease Monitoring? J Clin Med 2022;11:340. [PMID: 35054036 DOI: 10.3390/jcm11020340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Arnaud L. Épidémiologie du lupus systémique : des approches traditionnelles aux méga-données. Bulletin de l'Académie Nationale de Médecine 2022;206:17-22. [DOI: 10.1016/j.banm.2021.10.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Walhelm T, Gunnarsson I, Heijke R, Leonard D, Trysberg E, Eriksson P, Sjöwall C. Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study. Front Immunol 2021;12:756941. [PMID: 34659263 DOI: 10.3389/fimmu.2021.756941] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
13 Ceccarelli F, Lapucci M, Olivieri G, Sortino A, Natalucci F, Spinelli FR, Alessandri C, Sciandrone M, Conti F. Can machine learning models support physicians in systemic lupus erythematosus diagnosis? Results from a monocentric cohort. Joint Bone Spine 2021;89:105292. [PMID: 34655794 DOI: 10.1016/j.jbspin.2021.105292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Taub R, Horesh D, Rubin N, Glick I, Reem O, Shriqui G, Agmon-Levin N. Mindfulness-Based Stress Reduction for Systemic Lupus Erythematosus: A Mixed-Methods Pilot Randomized Controlled Trial of an Adapted Protocol. J Clin Med 2021;10:4450. [PMID: 34640468 DOI: 10.3390/jcm10194450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Li X, He Z, Ru L, Yuan Y, Yuan Z, Chen P, Xu Z, Wang Q, Song J, Xu Q. Efficacy and Safety of Qinghao Biejia Decoction in the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Front Pharmacol 2021;12:669269. [PMID: 34421590 DOI: 10.3389/fphar.2021.669269] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Kapsala N, Nikolopoulos D, Flouda S, Chavatza A, Tseronis D, Aggelakos M, Katsimbri P, Bertsias G, Fanouriakis A, Boumpas DT. First diagnosis of systemic lupus erythematosus in hospitalized patients: Clinical phenotypes and pitfalls for the non-specialist. Am J Med 2021:S0002-9343(21)00500-3. [PMID: 34411524 DOI: 10.1016/j.amjmed.2021.07.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Ene CD, Georgescu SR, Tampa M, Matei C, Mitran CI, Mitran MI, Penescu MN, Nicolae I. Cellular Response against Oxidative Stress, a Novel Insight into Lupus Nephritis Pathogenesis. J Pers Med 2021;11:693. [PMID: 34442337 DOI: 10.3390/jpm11080693] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
18 Moghazy A, Ibrahim AM. Impact and associations of lymphopenia in a cohort of Egyptian systemic lupus erythematosus patients: Potential link to complement (C3) and corticosteroids. The Egyptian Rheumatologist 2021;43:193-196. [DOI: 10.1016/j.ejr.2021.02.002] [Reference Citation Analysis]
19 Nasonov EL, Popkova TV, Panafidina TA. Problems of early diagnosis of systemic lupus erythematosus during the COVID-19 pandemic. Naučno-praktičeskaâ revmatologiâ 2021;59:119-128. [DOI: 10.47360/1995-4484-2021-119-128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]